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Mechanisticevidencelinkingchromosomalaberration(CA)toearly
stages of cancer has been recently supported by the results of epi-
demiological studies that associated CA frequency in peripheral
lymphocytes of healthy individuals to future cancer incidence. To
overcome the limitations of single studies and to evaluate the
strength of this association, a pooled analysis was carried out. The
pooled database included 11 national cohorts and a total of 22 358
cancer-free individuals who underwent genetic screening with CA
for biomonitoring purposes during 1965–2002 and were followed up
for cancer incidence and/or mortality for an average of 10.1 years;
368 cancer deaths and 675 incident cancer cases were observed.
Subjects were classiﬁed within each laboratory according to tertiles
of CA frequency. The relative risk (RR) of cancer was increased for
subjects in the medium [RR 5 1.31, 95% conﬁdence interval (CI) 5
1.07–1.60] and in the high (RR 5 1.41; 95% CI 5 1.16–1.72) tertiles
whencomparedwiththelowtertile.Thisincreasewasmostlydriven
by chromosome-type aberrations. The presence of ring chromo-
somesincreasedtheRRto2.22(95%CI5 1.34–3.68). The strongest
association was found for stomach cancer [RRmedium 5 1.17 (95%
CI 5 0.37–3.70), RRhigh 5 3.13 (95% CI 5 1.17–8.39)]. Exposure to
carcinogens did not modify the effect of CA levels on overall cancer
risk. These results reinforce the evidence of a link between CA
frequency and cancer risk and provide novel information on the
role of aberration subclass and cancer type.
Introduction
Lifestyle factors, environmental exposures and genetic background
interact in the development of many cancers. The use of phenotypic
markers that integrate the impact of environmental factors and genetic
processes would be of great value in risk assessment and surveillance
of populations occupationally or environmentally exposed to carcino-
gens. To date, the strongest mechanistic and epidemiological evidence
for such markers is available for chromosome damage (1–3).
The ﬁrst modern description of a speciﬁc chromosome abnormality
in a human tumour, i.e. the Philadelphia chromosome in chronic
myeloid leukaemia, was published almost 50 years ago (4), but only
with the introduction of banding techniques, the major role of chro-
mosomal rearrangements in carcinogenesis was fully recognized (5).
Subsequent observations that many genes affected by chromosomal
rearrangements were involved in critical stages in cell growth, de-
velopment or survival focused the interest of researchers on how the
rearrangements alter the function of these target genes. The model
linking chromosome breakage and rearrangement to the activation/
deactivation of genes relevant to early stages of carcinogenesis was
further reﬁned in the 1990s, when the use of the ﬂuorescence in situ
hybridization technique in irradiated cells contributed to understand-
ing the role of double-strand breaks in the formation of chromosomal
aberrations (CAs) and the implications of homology-dependent and
homology-independent pathways of double-strand break repair (1,6).
Althoughmechanisticevidencesupportingtheroleofchromosomal
alterations in early stages of cancer has been available for a long time,
the ﬁrst epidemiological data showing that the frequency of CA in
peripheral lymphocytes may predict cancer incidence in human pop-
ulations were published in early 1990s when two small cohort studies
were performed in healthy subjects scored for CA in the Nordic coun-
tries and Italy (7–9). Later analyses based on those cohorts suggested
that the cancer risk predictivity of CA is not modiﬁed by occupational
exposure to carcinogens or tobacco smoking, supporting the hypoth-
esis that the association between CA and cancer might be independent
of exposure (10). Other cohort studies published thereafter have gen-
erally conﬁrmed the results of the ﬁrst reports, with some discrepancy
in the strength of the associations between CA and cancer risk and in
the independence from exposure to carcinogens (11,12).
Theaimofthispooledanalysis,basedonoriginaldataof11national
cohort studies from Europe already published, was to provide a semi-
quantitative estimate of the association between CA and cancer risk,
a measure that could be used for risk assessment. Other goals were to
estimatetheassociationwithspeciﬁccancersitesandmajorsubclasses
ofCAandtheroleofexposuretocarcinogenicagentsaspotentialeffect
modiﬁers of the association between CA and cancer risk.
Materials and methods
The study design of all cohort studies included in the pooled analysis was
similar to the original approach used by the Nordic study group in the ﬁrst
studies published in the early 1990s (13). In brief, cancer-free subjects who
underwent CA screening for biomonitoring purposes—mostly due to occupa-
tional exposure to carcinogens and mutagens—were followed up from the date
of the ﬁrst CA test until the date of death, cancer diagnosis, emigration, 85th
Abbreviations: CA, chromosomal aberration; CI, conﬁdence interval; IR,
ionizing radiation; RR, relative risk.
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whichever occurred ﬁrst. To standardize for interlaboratory variation, all sub-
jects were classiﬁed within each laboratory according to tertiles of CA fre-
quency as follows: low (1–33 percentile), medium (34–66 percentile) or high
(67–100 percentile). The approach based on tertiles was the most efﬁcient
according to the Akaike information criteria (score 5 0.70 for total CA and
all cancers) when compared in the pooled database with other methods of
standardization such as z scores (score 5 0.72) and deviation from the mean
(score 5 0.72) (14).
Informationoncancerincidenceandmortalitywascollectedthroughlinkage
withnational/localcancerandcauseofdeathregistries.InHungaryandPoland,
anactivesystemoffollow-upformortalityandcancerincidencewassetup(12).
CA frequency was measured in cultured peripheral blood lymphocytes using
the classiﬁcation criteria of Savage (15). Only individuals with at least 100
scored metaphases were included in the database (.100 metaphases were
scored for 15% of subjects and .200 for 1.3%). Gaps were not included.
The culture time was 48 or 72 h. Tertiles for CA data based on 48 h culture
time (89.7% of the whole series) were evaluated separately from those with
72 h culture time. More detail about the study design and the quality proce-
dures implemented can be found in the original papers (7–12). The Italian
database included an additional unpublished cohort of 391 subjects, among
whom 9 cancer cases occurred at the end of the follow-up.
Pooled analysis
After obtaining approval by local institutional review boards, individual cyto-
genetic and epidemiological data from the original cohorts were collected and
entered in a pooled database. The information gathered in each cohort included
demographic data of the subject, the laboratory performing the assay, infor-
mation on exposure to genotoxic agents and smoking habits. CA data included
the date of the test; culture time; the number of cells scored and the number of
chromatid breaks, dicentrics, chromosome breaks, chromatid exchanges, ring
chromosomes, marker chromosomes and aberrant cells. Total CA frequency
was deﬁned as the number of cells with aberrations, excluding gaps, per
100 cells. Chromosome-type aberrations included chromosome-type breaks,
ring chromosomes, marker chromosomes and dicentrics, whereas chromatid-
type aberrations included chromatid-type breaks and chromatid exchanges.
The criteria for inclusion of individuals in the pooled analysis were valid de-
mographic data, at least 15 years of age and no cancer history at the time of the
CA test. Whenever a subject was analysed more than once, only the ﬁrst test
was considered for frequency classiﬁcation.
The pooled databases included a total of 22 358 subjects from 11 countries
and 45 laboratories screened for CA between 1965 and 2002 and followed up
for a median period of 10.1 years. The Czech data accounted for 48.3% of the
total persons-years. Details about the pooled cohort are reported in Table I.
Non-melanoma skin cancer was not systematically registered in the original
cohorts, and therefore, subjects suffering from this cancer were excluded from
the pooled analysis. This change contributed to small differences observed in
the number of subjects (24 subjects overall) and in the national risk estimates
with respect to published original data.
Information on occupational exposure at the time of the CA test was avail-
able for most subjects, although the quality of this information was heteroge-
neous among the cohorts. A common classiﬁcation scheme based on the
exposure groups identiﬁed by Tinnerberg et al. (16) was adopted. The most
frequent exposure was to ionizing radiation (IR), with 2974 subjects, followed
by exposure to cytostatic drugs (2521 subjects) and polycyclic aromatic hy-
drocarbon (2004 subjects). The group of non-exposed subjects included as
controls in some of the studies consisted of 3662 subjects. No data on occu-
pational exposure were available for cohorts from Sweden and Finland.
Information on smoking status at the time of the test was available for
18 766 subjects (83.9% of the total), among whom, 9657 were classiﬁed as
ever smokers(43.2%).The amountof cigarettessmokedper daywas registered
only in a few cohorts and the quality of these data was not comparable among
countries; therefore, this information was not used in the statistical analysis.
Statistical analysis
The pooledeffectofCAfrequencyoncancerrateswasestimated witha negative
binomial regression analysis (17). All estimates were adjusted for the concom-
itant effect of age (5 years age-class), gender, time since test (0–4, 5–9, 10–14,
15–19 and  20 years), smoking habit (ever/never/former) and occupational
exposure to carcinogens (yes/no). Relative risks (RRs) were estimated according
to different levels of CA frequency together with its 95% conﬁdence intervals
(CIs). The presence of a linear trend of RRs was tested with the v2 trend test.
To take into account the different magnitude of cancer rates in each country,
a random intercept model was ﬁtted to the data to estimate the variance com-
ponent due to the between-countries variability. A random slope model was
performed to verify if the CA effect on cancer rates varied between countries
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CA frequency in lymphocytes predicts cancer risk
1179(18). These models allowed us to estimate the amount of heterogeneity present
in the data andaccordingly providedsuitableestimatesof the standarderrors of
the combined effects. A sensitivity analysis was performed to examine the
variations in the pooled effect estimates due to the exclusion of one country
at a time. Similarly, other sensitivity analyses were performed to evaluate the
potential impact of an unbalanced distribution of main cohort characteristics
such as culture time or the number of cells scored.
The potential effect modiﬁcation of exposure to carcinogens on the main
association between CA frequency and cancer was explored by means of the
likelihoodratiotest,i.e. comparingtwo hierarchicalregressionmodelsfor each
major exposure category identiﬁed by the exposure matrix, with and without
the interaction term, respectively (18).
To test the possibility that pre-clinical stages of cancer may have inﬂuenced
CA frequency, we repeated the analysis excluding the ﬁrst 2 years of follow-up
and also tested a possible effect modiﬁcation due to time since test.
Additional analyses were performed by country, by type of CA including
subclasses and for cancer sites with at least 10 observed cases.
Kaplan–Meier product-limit method was applied to estimate the elapsed
timewithoutcancer at different CA levels. Theproportionalhazardassumption
was not rejected based on the approach suggested by Grambsch et al. (19)
[v2(2 df) 5 1.14, P 5 0.57].
The computer softwares MLwiN (20) and STATA (21) were used for the
statistical analysis.
Results
An overall number of 675 incident cancers and 368 cancer deaths
were registered at the end of the follow-up. The two end points were
analysed independently. The most frequent cancer sites were lung
(99 incident cases and 100 deaths), colon and rectum (88 and 53),
bladder and kidney (76 and 28), breast (76 and 11) and the lympho-
haematopoietic system (46 and 30).
The results on the association between overall cancer incidence and
CA frequency in the whole database are reported in Table II. The RR
was increased for subjects in the medium (RR 5 1.31, 95% CI 5
1.07–1.60) and in the high (RR 5 1.41, 95% CI 5 1.16–1.72) tertiles
of the total CA distribution when compared with the low tertile (test
for linear trend, P5 0.001). An increase in RR was seen within the
subclass of chromosome-type aberrations, i.e. 1.29 (95% CI 5
1.05–1.59) and 1.42 (95% CI 5 1.17–1.71) for medium and high
tertiles (test for linear trend, P, 0.001), respectively, but not for
chromatid-type aberrations. Among the subclasses of CAs, the RR
for the presence of ring chromosomes was 2.22 (95% CI 5
1.34–3.68), whereas the non-signiﬁcant RRs of other types of chro-
mosomal abnormalities (dicentrics, chromatid exchanges and
markers) ranged between 1.30 and 1.39.
A similar pattern of risk was found for mortality. Subjects in the
medium tertile of total CA distribution experienced an RR of 1.36
(95% CI 5 1.04–1.81, deaths 5 136) and those in the high tertile an
RR of 1.35 (95% CI 5 1.03–1.80, deaths 5 154). The RR for the two
main classes of CA followed the same pattern observed for cancer
incidence. The presence of marker chromosomes entailed a mortality
RR of 1.71 (95% CI 5 0.97–3.02).
Although increased risks were observed in all cohorts but Finland
(with the highest RRs in Hungary and in Norway), country-speciﬁc
results showed a certain degree of heterogeneity, and the relationship
between RRs of medium and high CA tertiles was equivocal in some
countries (Figure 1). However, ﬁtting a random slope model to the
data did not provide strong evidence of between-country heterogene-
ity in CA effect [v2 5 1.92 (2 df), P5 0. 38]. Furthermore, to evaluate
if the overall association between CA and cancer risk was driven by
a speciﬁc country, a sensitivity analysis was performed, sequentially
removing a country from the analysis. The most extreme difference in
RRs was obtained by removing the Czech Republic (increase to
RRmedium 5 1.32, RRhigh 5 1.64) and Hungary (decrease to RRmedium
5 1.25, RRhigh 5 1.29) from the pooled analyses. In all cases, RRs
remained signiﬁcantly increased.
No covariate tested as potential effect modiﬁer, i.e. gender, smok-
ing habit, age, time from test and occupational exposure, was found to
signiﬁcantly modify the effect of CA levels on overall cancer risk in
the whole cohort. In the analysis excluding the ﬁrst 2 years of obser-
vation, the results on the association between CA and cancer inci-
dence were not modiﬁed [597 cancer cases, RRmedium 5 1.33 (95%
CI 5 1.07–1.66), RRhigh 5 1.46 (95% CI 5 1.18–1.81)]. Similarly,
the analyses stratiﬁed by median duration of follow-up did not yield
different results in the two periods (data not shown).
In the analysis of speciﬁc types of cancer, the strongest association
was found for stomach cancer [32 cases, RRmedium 5 1.17 (95% CI 5
0.37–3.70),RRhigh 53.13 (95%CI 51.17–8.39); testforlinear trend, Table II. RRs of cancer incidence by type of CAs (All tumours - ICD IX
140–208)
Type of CA Subjects Cases Person-years RR 95% CI
Total CAs
Low
a 6399 152 63 210 1 —
Medium 7456 240 71 956 1.31 1.07–1.60
High 6438 283 70 463 1.41 1.16–1.72
Chromatid-type aberrations
Low
a 6026 185 60 523 1 —
Medium 7146 226 69 696 1.10 0.90–1.35
High 6870 252 72 106 1.12 0.92–1.36
Chromosome-type aberrations
Low
a 8521 195 84 273 1 —
Medium 5366 207 55 311 1.29 1.05–1.59
High 6150 261 62 702 1.42 1.17–1.71
Dicentric chromosomes
No
a 7288 253 78 632 1 —
Yes 976 52 10 432 1.32 0.96–1.80
Ring chromosomes
No
a 7542 255 78 058 1 —
Yes 188 20 1941 2.22 1.34–3.68
Chromatid exchanges
No
a 4621 158 51 466 1 —
Yes 498 25 5550 1.30 0.83–2.01
Marker chromosomes
No
a 4849 163 53 121 1 —
Yes 270 20 3895 1.39 0.84–2.30
ICD, International Classiﬁcation of Diseases.
RRs were adjusted for country, gender, age, time since test, job exposure and
smoking habit.
aReference category.
Fig. 1. Country-speciﬁc RR of cancer by frequency of CAs. RR was
adjusted for gender, age, time since test, job exposure and smoking habit and
was expressed in log scale to improve the readability of the ﬁgure. Symbols
indicate RR by CA category, bars represent CIs. Reference category is the
low tertile. RRs from Denmark could not be estimated because no cancer
cases occurred in the reference group.
S.Bonassi et al.
1180P 5 0.009], whereas the results for other cancer sites were only
suggestive of an association (Table III). Analysis based on cancer
mortality showed comparable results except for neoplasms of the
lymphohaematopoietic system, for which an association with
CA frequency [30 cases, RRmedium 5 2.39 (95% CI 5 0.77–7.45),
RRhigh 5 2.61 (95% CI 5 0.85–8.02)] was suggested. No country-
speciﬁc effect was found for any cancer site, but this analysis was
hampered by small numbers.
As a whole, subjects exposed to genotoxic agents did not present
a signiﬁcant increase of cancer risk when compared with non-exposed
subjects [RR 5 1.08 (95% CI 5 0.86–1.36)]; however, some exposure
groups showed increased risks for speciﬁc cancer sites, such as lung
cancer in workers exposed to IR [RR 5 2.71 (95% CI 5 1.14–6.43)].
The association of cancer risk with CA frequency was particularly
evident in workers exposed to IR [2974 subjects, RRmedium 5 2.01
(95% CI 5 1.15–3.51), RRhigh 5 1.81 (95% CI 5 1.03–3.20)] and at
a lower extent in groups exposed to polyvinyl chloride and plastics
[945 subjects, RRmedium 5 1.62 (95% CI 5 0.53–4.96), RRhigh 5 1.73
(95% CI 5 0.58–5.19)], metals [662 subjects, RRmedium 5 3.10 (95%
CI 5 0.64–14.97), RRhigh 5 2.75 (95% CI 5 0.59–12.80)] and weld-
ing fumes [392 subjects, RRmedium 5 2.01 (95% CI 5 0.42–9.51),
RRhigh 5 2.63 (95% CI 5 0.56–12.28)]. The RRs among subjects not
exposed to occupational carcinogens were 1.39 (medium, 95% CI 5
0.86–2.25) and 1.54 (high, 95% CI 5 0.90–2.64). Each occupational
category was tested as a possible effect modiﬁer of the association
between CA and overall cancer risk, and none of the interaction terms
were signiﬁcant. The presence of effect modiﬁcation due to occupa-
tional exposure to carcinogens was tested also for subclasses of CA
and for major groups of cancer. All interactions tested turned out to be
non-signiﬁcant.
A similar analysis was performed to test the effect modiﬁcation of
cigarette smoking. When compared with non-smokers, ever smokers
experienced an increased risk of all cancers (RR 5 1.53, 95% CI 5
1.28–1.83) and especially lung cancer (RR 5 6.65, 95% CI 5
3.17–13.95). The association between CA and risk of cancer was
stronger in ever smokers [316 cases, RRmedium 5 1.42 (95% CI 5
1.04–1.94),RRhigh 51.54 (95%CI 51.14–2.08); testforlinear trend,
P 5 0.008] than in non-smokers [208 cases, RRmedium 5 1.30 (95%
CI 5 0.93–1.82), RRhigh 5 1.18 (95% CI 5 0.83–1.68)], but the
interaction was not statistically signiﬁcant (P 5 0.53).
The association between cancer risk and CA frequency was con-
sistent over the follow-up time, as shown by the Kaplan–Meier curves
of the probability to be cancer free (Figure 2), which indicated a sig-
niﬁcantly worse outcome in subjects in the medium and high CA
tertiles (log-rank test P , .001). Survival curves based on cancer
mortality showed similar results (data not shown).
Discussion
The results of the present study, which included data from all CA
cohorts published so far, conﬁrm that CA frequency measured in
peripheral blood lymphocytes of healthy subjects is associated with
cancer risk, although the strength of this conclusion is somewhat
weakened by the lack of a clear dose–response in most national co-
horts. The independence of these ﬁndings from the time elapsed
between cytogenetic testing and cancer diagnosis supports the as-
sumption that increased CA levels in high-risk subjects are not attrib-
utable to clinically undetected cancers.
The pooled approach applied in this study gave several advantages
overameta-analysisofpublisheddata,includingthepossibilitytoper-
form interaction tests and subgroup analyses. Nevertheless, pooling
data of biomarkers such as CA, which are characterized by variability
of protocols, equipment and methods, may pose a serious question of
heterogeneity. To address this issue, data from each laboratory were
categorized in three frequency categories, an approach which accord-
ing to the Akaike information criteria was more efﬁcient than other
methods of standardization.
A possible source of misclassiﬁcation is the use of a single CA
measure to classify subjects according to CA frequency. Due to the
availability of a repeated measure for 11 909 subjects in the Czech
cohort (99.3%), we could evaluate the agreement between the two
measures in this database. 76.1% of these subjects were classiﬁed in
the same category for both tests, whereas for 11.6 and 12.2%, the
second test would have resulted in a higher or lower class compared
with the ﬁrst test, respectively. To evaluate if the choice of the test
may have inﬂuenced the strength or the direction of the association,
we compared risk estimates based on tertiles calculated with the ﬁrst
and the second assay. The results were very similar, i.e. RRmedium 5
1.27 and 1.24 and RRhigh 5 1.17 and 1.21, respectively, showing that
the classiﬁcation based on a single measure of CA—at least in the
Czech cohort—did not affect the estimate of the association between
CA and cancer.
Table III. Cancer-speciﬁc RRs for frequency of CAs
Cancer site (ICD IX) CA tertile
Low
a Medium High
Cases Cases RR 95% CI Cases RR 95% CI
All cancers (140–208) 152 240 1.31 1.07–1.60 283 1.41 1.16–1.72
Mouth and pharynx
(140–149)
7 5 0.55 0.17–1.74 15 1.47 0.60–3.63
Stomach (151) 5 7 1.17 0.37–3.70 20 3.13 1.17–8.39
Colon and rectum
(153–154)
20 31 1.24 0.71–2.18 37 1.30 0.75–2.24
Liver and biliary ducts
(155–156)
4 4 0.85 0.21–3.42 11 2.13 0.68–6.74
Pancreas (157) 3 6 1.66 0.42–6.66 7 1.69 0.44–6.58
Lung (162) 22 28 0.98 0.56–1.71 49 1.37 0.83–2.27
Melanoma (172) 3 6 1.74 0.43–7.01 9 2.65 0.71–9.92
Breast (174) 22 31 1.23 0.71–2.13 23 0.95 0.53–1.72
Female genital tract
(179–183)
11 24 1.81 0.88–3.69 17 1.36 0.63–2.91
Prostate (185) 10 9 0.82 0.33–2.01 26 1.92 0.91–4.02
Bladder and kidney
(188–189)
19 35 1.50 0.86–2.63 22 0.81 0.44–1.50
Lymphohaematopoietic
system (200–208)
11 18 1.40 0.66–2.97 17 1.29 0.60–2.76
ICD, International Classiﬁcation of Diseases.
RRs were adjusted for country, gender, age, time since test, job exposure and
smoking habit.
aReference category.
Fig. 2. Kaplan–Meier curves for total cancer incidence (International
Classiﬁcation of Diseases IX 140–208) tertile of CA frequency based on
pooled data from 11 European cohorts. Cancer-free probability refers to time
from CA test to the ﬁrst cancer diagnosis.
CA frequency in lymphocytes predicts cancer risk
1181The interpretation of the study ﬁndings at country level is complex.
Although a dose–response was present only in Hungary and Norway
(test for linear trend, P 5 0.002 and P 5 0.030, respectively), the risk
estimates were above unity in most cohorts, conﬁrming the impor-
tance of a pooled design to reach the adequate statistical power to test
this hypothesis.
The large size of the pooled database allowed us to investigate in
greater detail hypotheses not properly tested in the original studies, in
particular, whether the frequency of chromosome-type and chroma-
tid-type aberrations has a different predictive value for cancer risk.
The question is of great relevance since the induction of these aberra-
tions reﬂects different mechanisms. In peripheral lymphocytes, chro-
mosome-type CAs are induced by IR and other S-independent
clastogens, causing DNA double-strand breaks, whereas chromatid-
type CAs are produced by S-dependent agents such as many chemical
mutagens. The published evidence is contrasting since earlier Nordic–
Italian studies found that both subclasses are equally predictive of
cancer risk (22), whereas the larger cohorts from the Czech Republic
(11) and Central Eastern European countries (12) suggest that chro-
mosome-type CA may show a stronger association. The results of the
pooled estimates reﬂect the prevailing effect found in these latter
cohorts. However, the limited improvement over the results based
on total CA does not support the use of chromosome-type aberrations
as the most predictive biomarker of risk.
The increased cancer risk observed in subjects bearing ring chro-
mosomes (20 cases) and the borderline increase observed for marker
chromosomes (limited to mortality) are not circumstantiated enough
to be considered for future risk assessment protocols, and chance of
error measurement remain plausible explanations. However, these
ﬁndings should further be considered, given the mechanistic evidence
linking chromosomal rearrangements to early stages of cancer.
Information about subclasses of chromosome- and chromatid-type
aberrations was available only for a part of the cohort. To check if this
subgroup was representative of the whole cohort, we re-evaluated
cancer risks associated with total CA frequency in the same subset
of subjects. The results were in agreement with a random selection of
the population, showing risks very similar to those of thewhole cohort
[RRmedium 5 1.40 (95% 5 1.01–1.92), RRhigh 5 1.67 (95% CI 5
1.22–2.28)].
The hypothesis that CA frequency is associated with speciﬁc can-
cers has been investigated since the ﬁrst cohort studies. A stronger
association was initially described with lung cancer and haematolog-
ical malignancies (8), whereas more recently, based on larger num-
bers, both the Czech cohort (11)and the Central and Eastern European
country cohort (12) reported an increased risk of stomach cancer. The
analysis of this pooled databases showed the association of CA fre-
quency with stomach cancer as the only cancer site signiﬁcantly as-
sociated with CA frequency (Table III). The hypothesis of a spurious
association due to the number of comparisons cannot be ruled out;
however, there is supportive mechanistic evidence. The presence of
chromosome instability among the most relevant events in intestinal
and diffuse stomach cancers has extensively been described (23,24)
and linked to the metabolisms of agents involved in stomach carcino-
genesis, such as folic acid and vitamin B12 (25,26). Interestingly,
a recently publishedcohort study linkingthe frequency of micronuclei
in lymphocytes of healthy subjects to the risk of cancer reported
stomach cancer among the sites more speciﬁcally associated with
micronuclei frequency (27). A recent report indicated that Helico-
bacter pylori infection is associated with an increased level of micro-
nuclei in peripheral lymphocytes (28).
Another open issue is the role of exposures to genotoxic and car-
cinogenic agents experienced by study subjects at the time of CA
testing. A nested case–control study carried out within the Nordic–
Italian databases to speciﬁcally test the presence of interaction of CA
frequency with major occupational exposure to carcinogens and with
cigarette smoking did not ﬁnd any difference in the risks (10). How-
ever, this independence was later put in doubt by the observation that
in a subcohort of Czech miners exposed to radon, subjects with high
levels of CA showed a much higher risk of cancer than those in other
occupational groups of the same cohort (29). In the present study, the
non-homogeneous quality of exposure assessment among studies lim-
ited the possibility to test by the presence of interaction. However,
with an exploratory approach, study subjects were grouped by geno-
toxic exposure and risks were estimated within each subcohort. The
small increase of cancer risk in thewhole group of workers exposed to
carcinogens when compared with non-exposed workers can be ex-
plained by exposure misclassiﬁcation. The reliability of the design
was conﬁrmed by the high risks found for well-known associations
between carcinogenic agents and tumour sites, such as those reported
previously for lung cancer in exposure to IR. No clear evidence of
effect modiﬁcation was found for any exposure, although there was
a suggestion of a higher risk associated with CA frequency for sub-
jects exposed to IR. The estimate of cancer risk associated with
smoking habit was more reliable, as supported by the close to ex-
pected RRs found in smokers for all cancers and lung cancer. How-
ever, also for this exposure, results of the interaction tests—although
affected by a limited statistical power—are in agreement with the
hypothesis that exposure is not an effect modiﬁer of the association
between CA and cancer.
The results of this study represent the synthesis of research
conducted over two decades aiming at validating biomarkers of chro-
mosomal damage as predictors of cancer occurrence in groups of
healthy individuals. One of the indirect results of this effort was the
establishment of an international database of over 20 000 subjects
screened for CA, which can be followed up to provide further and
more reliable data regarding the use of this biomarker to identify high-
risk populations.
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